Columbia University experts caution that unchecked AI deployment in imaging may lead to a 'zombie algorithm' crisis and a looming technology bubble in healthcare.
Key Details
- 1Columbia University scientists warn of the 'zombie algorithm phenomenon' affecting medical imaging and other medical fields.
- 2Global tech companies are investing $250 billion annually in AI, with U.S. healthcare as a key sector.
- 3A survey found that U.S. healthcare AI adoption outpaces other industries by 2.2 times, reaching $1.4 billion in investments last year.
- 4MIT's NANDA Initiative estimates that 95% of enterprise generative AI pilots fail to deliver measurable financial returns.
- 5Experts argue AI implementation is advancing faster than oversight and actual evidence of benefit.
Why It Matters
Rapid, unproven AI deployment in radiology could erode trust and lead to ineffective or harmful outcomes. This call for a 'course correction' urges the imaging community to prioritize evidence, oversight, and evaluation of AI solutions.
Source
Radiology Business
Related News
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•AuntMinnie
Vast Majority of FDA-Cleared Radiology AI Devices Lack Outcome Trials
Only 0.3% of FDA-cleared radiology AI devices have registered trials on patient outcomes, raising concerns about evidence standards.
•AuntMinnie
Radiology Leads FDA AI Device Approvals Over Three Decades
Radiology accounts for 76% of all FDA-cleared AI/ML-enabled medical devices as of the end of 2025.